Author:
Metrebian N.,Weaver T.,Pilling S.,Hellier J.,Byford S.,Shearer J.,Mitcheson L.,Astbury M.,Bijral P.,Bogdan N.,Bowden-Jones O.,Day E.,Dunn J.,Finch E.,Forshall S.,Glasper A.,Morse G.,Akhtar S.,Bajaria J.,Bennett C.,Bishop E.,Charles V.,Davey C.,Desai R.,Goodfellow C.,Haque F.,Little N.,McKechnie H.,Morris J.,Mosler F.,Mutz J.,Pauli R.,Poovendran D.,Slater E.,Strang J.
Funder
Programme Grants for Applied Research Programme
Trial Steering Committee
Service User Research Advisory Group and Anthea Martin
Subject
Pharmacology (medical),General Medicine
Reference41 articles.
1. National Drug Evidence Centre. Statistics from the National Drug Treatment Monitoring System (NDTMS) April 2012/2013.
2. Drug Misuse;National Institute for Care Excellence (NICE),2006
3. Economic analysis of costs and consequences of the treatment of drug misuse: 2-year outcome data from the National Treatment Outcome Research Study (NTORS);Godfrey;Addiction,2004
4. From Access to Recovery: analysing Six Years of Drug Treatment Data;National Treatment Agency for Substance Misuse (NTA),2012
5. A meta-analysis of voucher-based reinforcement therapy for substance use disorders;Lussier;Addiction,2006